KalVista Pharmaceuticals, Inc.【KALV】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
3Q25
|
-49,482
|
+70.5%
|
|
1Q26
|
-60,096
|
+48.6%
|
|
4Q25
|
-52,226
|
+17.0%
|
|
3Q25
|
-48,508
|
+67.1%
|
|
2Q25
|
-42,267
|
+52.9%
|
|
1Q25
|
-40,443
|
+59.7%
|
|
4Q24
|
-44,649
|
+69.7%
|
|
3Q24
|
-29,028
|
+36.3%
|
|
2Q24
|
-27,650
|
+24.2%
|
|
1Q24
|
-25,317
|
+9.9%
|
|
4Q23
|
-26,305
|
+9.1%
|
|
3Q23
|
-21,303
|
-5.2%
|
|
2Q23
|
-22,257
|
+13.3%
|
|
1Q23
|
-23,042
|
+43.0%
|
|
4Q22
|
-24,113
|
+61.2%
|
|
3Q22
|
-22,467
|
+123.6%
|
|
2Q22
|
-19,649
|
+88.5%
|
|
1Q22
|
-16,109
|
+49.0%
|
|
4Q21
|
-14,956
|
+127.2%
|
|
3Q21
|
-10,047
|
+8.1%
|
|
2Q21
|
-10,426
|
+76.6%
|
|
1Q21
|
-10,814
|
+47.4%
|
|
4Q20
|
-6,584
|
-22.8%
|
|
3Q20
|
-9,291
|
+134.9%
|
|
2Q20
|
-5,903
|
+78.7%
|
|
1Q20
|
-7,338
|
+45.9%
|
|
4Q19
|
-8,526
|
+1197.7%
|
|
3Q19
|
-3,956
|
-24.4%
|
|
2Q19
|
-3,304
|
-33.7%
|
|
1Q19
|
-5,030
|
+2.1%
|
|
4Q18
|
-657
|
-84.4%
|
|
3Q18
|
-5,234
|
-31.5%
|
|
2Q18
|
-4,986
|
-
|
|
1Q18
|
-4,928
|
-
|
|
4Q17
|
-4,202
|
-
|
|
3Q17
|
-7,644
|
+220.5%
|
|
3Q16
|
-2,385
|
-52.2%
|
|
2Q16
|
-7,350
|
-18.4%
|
|
1Q16
|
-6,607
|
+27.4%
|
|
4Q15
|
-5,659
|
-
|
|
3Q15
|
-4,991
|
-
|
|
2Q15
|
-9,012
|
-
|
|
1Q15
|
-5,184
|
-
|